top of page
Supported projects
TATUM Bioscience
A start-up biotech wich develops bioengineered nanofilaments, a new class of immunotherapies, designed to bind to cancer cells and mark them for immune attack.
PSCC's entrance
September 2025
Localization
Canada
Modality
Immunotherapy
Development status
Biotech - Pre-IND/ CTA
Award(s)
bottom of page